查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923621

长读长定序服务市场：依技术、服务供应商、应用程式和最终用户划分－2026-2032年全球预测

Long-Read Sequencing Services Market by Technology, Service Provider, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年长读定序服务市值为 7.3536 亿美元，预计到 2026 年将成长至 8.511 亿美元，年复合成长率为 16.14%，到 2032 年将达到 20.9655 亿美元。

关键市场统计数据
基准年 2025 7.3536亿美元
预计年份：2026年 8.511亿美元
预测年份 2032 2,096,550,000 美元
复合年增长率 (%) 16.14%

清晰权威地介绍了长读长定序服务，将其作为关键平台技术，帮助复杂的基因组分析和临床应用。

长读长定序服务已成为先进基因组分析的基础技术，弥合了高解析度研究需求与临床应用目标之间的鸿沟。该技术能够发现结构变异、捕获全长转录本并分析复杂的基因组区域，从而彻底改变了基础科学、转化研究和诊断开发中的实验设计。随着相关人员重新评估其优先事项，服务供应商在将尖端仪器、资讯处理流程和样本处理专业知识转化为可操作成果方面，正日益成为不可或缺的合作伙伴。

对正在重塑长读定序交付和应用的变革性技术、商业性和应用主导型转变进行了深入的综合分析

长读长定序领域正经历一场变革，这场变革由三个相互关联的动态所驱动：技术日趋成熟、服务模式不断演进以及应用领域日益扩展。技术供应商不断改进读取准确性、通量和成本结构，使服务供应商能够将其服务范围从概念验证计划扩展到常规的高复杂度研究。因此，客户现在期望获得端到端的服务，将原始数据生成与高级分析相结合，从而揭示表观遗传标记、结构变异和全长转录本异构体。

对2025年关税变化对定序服务供应商的供应链、筹资策略和营运弹性的影响进行实际分析

2025年关税和贸易政策调整的实施，为定序耗材、仪器及相关试剂的供应链带来了新的复杂性，并对营运成本和整体筹资策略产生了连锁反应。依赖进口的组件，例如专用流动池、专有酵素和高性能耗材，面临更严格的进口审查和物流延误，迫使许多服务供应商重新评估其库存管理政策和供应商多元化策略。实际上，采购部门正在增加安全库存并确保多个供应商，以保障计划进度；而财务部门则在审查合约条款，以吸收或转嫁不断增加的成本压力。

透过对应用程式、技术、最终用户和服务供应商类型进行多层次細項分析，揭示了不同的需求驱动因素和提供者的专业化要求。

从应用、技术、终端用户和服务供应商的观点分析市场，可以发现需求和专业化的细微差别。按应用领域划分，服务使用涵盖表观遗传学、总体基因体学定序、结构变异分析、转录组定序和全基因测序。其中，转录组定序进一步细分为批量定序和单细胞定序，全基因测序则分为人类和非人类工作流程。这些不同的应用对读长、碱基准确性和样本处理提出了不同的要求，从而影响服务提供者的专业化程度，并进而影响平台采用和分析投资决策。

从战略区域观点比较美洲、欧洲、中东和非洲以及亚太地区的采用驱动因素、监管复杂性和容量趋势

区域趋势对服务可近性、伙伴关係模式和监管预期有显着影响。美洲是转化研究和临床诊断的中心，生物技术公司、学术医疗中心和製药公司总部密集分布，推动了对高通量服务和专业检测的需求。这种集中化促进了新通讯协定的快速应用，并创造了竞争激烈的环境，服务供应商必须展现卓越的营运能力并遵守国家法规结构。

重点检验长读定序服务中构成公司优势的竞争差异化、伙伴关係建立和卓越营运。

长读长定序服务领域的公司竞争主要集中在技术的一致性、服务范围以及提供可重复且符合监管要求的结果的能力。开发精准化学技术和可扩展流动池的技术供应商透过帮助服务供应商拓展高通量或临床级服务，从而影响服务格局。同时，服务机构则透过流程标准化、生物资讯学专业知识以及面向客户的能力（例如安全的资料管道和可自订的报告格式）来脱颖而出。

为提升竞争优势，提供如何协调平台选择、供应链韧性和整合服务模式的实用建议

产业领导者应采取多管齐下的策略，将技术能力与商业性灵活性和供应链韧性结合。首先，应优先进行平台适用性分析，将结构变异检测、天然甲基化评估和单细胞转录组学等应用需求与现有平台的技术优势和限制相匹配。这种匹配能够确保资金的高效配置，并减少因检测设计与平台性能不匹配而导致的返工。

我们采用透明且可复製的调查方法，结合专家访谈、营运评估和二手资讯整合，检验我们的发现和结论。

本分析的调查方法结合了质性专家调查、二手文献综述和结构化运作评估。主要资讯透过访谈实验室主任、服务采购人员和平台工程师收集，以了解他们对技术性能、供应商关係和运作挑战的现场观点。此外，还系统地审查了技术文件、法规指南、製造商规格和同行评审文献，以确保对平台的功能和应用适用性进行准确描述。

这是一份简洁的概述，它将技术、商业策略和营运韧性联繫起来，为长读定序服务的相关人员提供切实可行的视角。

总之，长读长定序服务正处于转折点。技术成熟度、不断演进的服务模式以及不断变化的宏观经济经济状况相互交织，既带来了机会，也带来了挑战。能够将平台功能与明确的应用需求相匹配、投资于供应链韧性并提供整合分析方案的供应商，将更有能力满足生物技术公司、诊断检查室、製药公司和研究实验室的多元化需求。策略差异化将不再仅仅取决于设备所有权，而是更多地取决于提供可重复、符合监管要求且以洞察为导向的服务的能力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依技术分類的长读长定序服务市场

  • 牛津奈米孔
  • 太平洋生物科学

9. 长读长定序服务市场（依服务提供者划分）

  • 学术核心设施
  • CRO（受託研究机构）
  • 医院检查室

第十章：按应用分類的长读长定序服务市场

  • 表观遗传分析
  • 总体基因体学
  • 结构突变分析
  • 转录定序
    • 大部分
    • 单细胞
  • 全基因组定序
    • 人类
    • 非人类

第十一章 依最终用户分類的长读长定序服务市场

  • 生技公司
  • 诊断检查室
  • 製药公司
  • 研究所

第十二章：按地区分類的长读长定序服务市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 按组别分類的长读长定序服务市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国长读长定序服务市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国长读长定序服务市场

第十六章：中国的长读长定序服务市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arima Genomics, Inc.
  • Azenta, Inc.
  • Bionano Genomics, Inc.
  • Circulomics, Inc.
  • DNAnexus, Inc.
  • Eurofins Genomics LLC
  • Fulgent Genetics, Inc.
  • Genewiz, Inc.
  • LGC Genomics Ltd.
  • MicrobesNG Ltd.
  • Nucleics Pty Ltd
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Plenty Labs Inc.
  • Primordium Labs LLC
  • Psomagen, Inc.
  • Ramaciotti Centre for Genomics
  • SeqCenter LLC
  • Sequencing.com, Inc.
  • The Genome Analysis Centre Ltd.
  • Veritas Genetics, Inc.
  • Whole Genome Corporation
Product Code: MRR-867BED9AA0A2

The Long-Read Sequencing Services Market was valued at USD 735.36 million in 2025 and is projected to grow to USD 851.10 million in 2026, with a CAGR of 16.14%, reaching USD 2,096.55 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 735.36 million
Estimated Year [2026] USD 851.10 million
Forecast Year [2032] USD 2,096.55 million
CAGR (%) 16.14%

A clear and authoritative introduction that frames long-read sequencing services as critical enablers of complex genomic discovery and clinical translation

Long-read sequencing services have emerged as a foundational capability for advanced genomic analysis, bridging the gap between high-resolution research needs and translational clinical ambitions. The technology's ability to resolve structural variation, capture full-length transcripts, and interrogate complex genomic regions has reshaped experimental design across basic science, translational research, and diagnostic development. As stakeholders recalibrate priorities, service providers are increasingly positioned as essential partners that translate cutting-edge instrumentation, informatics pipelines, and sample handling expertise into actionable results.

In practice, the adoption trajectory reflects a convergence of technical maturation and growing demand for assays that are difficult to accomplish with short-read approaches alone. This has elevated the role of specialized service providers who can offer end-to-end workflows, from sample QC and library preparation through sequencing and downstream analysis. Consequently, research consortia, clinical laboratories, and commercial organizations are re-evaluating sourcing strategies to prioritize providers that combine throughput flexibility, technical reproducibility, and regulatory-compliant data governance.

Importantly, the ecosystem is not monolithic: differences in platform architecture, read-length capabilities, and analytical toolchains create variation in how services are packaged and delivered. Therefore, purchasers must assess providers not only on throughput and cost but on the fit between technological strengths and the biological questions at hand. A pragmatic introduction to this landscape requires focusing on capabilities, operational models, and the interplay between platform selection and downstream bioinformatics.

An incisive synthesis of the transformative technological, commercial, and application-driven shifts reshaping long-read sequencing service delivery and adoption

The long-read sequencing landscape is experiencing transformative shifts driven by three intertwined dynamics: technological refinement, service model evolution, and the expansion of application domains. Technology vendors have pursued iterative enhancements in read accuracy, throughput, and cost dynamics, which in turn enable service providers to broaden their offerings beyond proof-of-concept projects into routine, high-complexity studies. As a result, clients now expect end-to-end service offerings that combine raw data generation with sophisticated analysis capable of resolving epigenetic marks, structural variants, and full-length transcript isoforms.

Simultaneously, service models are evolving from ad hoc, project-based engagements to more integrated and recurring partnerships. Contract research organizations, hospital laboratories, and academic core facilities are each carving distinct value propositions: CROs emphasize regulatory readiness and turnkey development; hospital labs highlight clinical validation and patient-centric workflows; academic cores stress method development and customizable protocols. These models are converging around greater emphasis on quality management and analytics reproducibility, enabling multi-site studies and cross-institutional collaboration.

Emerging application areas are also reshaping demand. Beyond whole genome and transcriptome interrogation, investigators are leveraging long reads for metagenomics to resolve complex microbial communities and for epigenetic analyses that require native DNA and direct methylation calling. Consequently, service providers that integrate platform-specific strengths with bespoke analytical pipelines are gaining traction, and the boundary between instrument vendor capability and service offering is becoming increasingly fluid. These shifts underscore the need for strategy that aligns platform selection, data governance, and commercialization pathways.

A practical analysis of how 2025 tariff changes have distorted supply chains, procurement strategies, and operational resilience across sequencing service providers

The introduction of tariffs and trade policy adjustments in 2025 has introduced new complexity into supply chains for sequencing consumables, instruments, and associated reagents, creating a ripple effect across operational costs and procurement strategies. Import-dependent components such as specialized flow cells, proprietary enzymes, and high-performance consumables have faced elevated import scrutiny and logistical delays, prompting many service providers to reassess inventory policies and supplier diversification strategies. In practical terms, procurement teams have increased safety stocks and pursued multi-sourcing to protect project timelines, while finance teams have revisited contract terms to absorb or pass through incremental cost pressures.

These dynamics have also accelerated regionalization efforts in sourcing and manufacturing. Manufacturers and distributors have prioritized near-shore partnerships where feasible, and some service providers have elected to relocate critical inventory or establish regional distribution agreements to mitigate exposure to tariff volatility. Meanwhile, longer lead times for certain instrument components have influenced scheduling for large-scale projects, pushing teams to plan further ahead and to incorporate contingency buffers into study timelines.

Regulatory and compliance implications are equally important. Tariff-driven cost increases have placed renewed emphasis on demonstrating operational value and cost-effectiveness to payers, funders, and clients. For clinical and diagnostic users, supply-chain resilience has become a criterion for vendor selection, requiring transparent documentation of sourcing pathways and continuity plans. In sum, the cumulative impact of tariffs in 2025 extends beyond unit costs to influence partnering decisions, inventory governance, and strategic planning across the ecosystem.

A layered segmentation insight that maps applications, technologies, end users, and service provider types to reveal distinct demand drivers and provider specialization imperatives

Delineating the market through application, technology, end user, and service provider lenses reveals nuanced patterns of demand and specialization. Based on application, service uptake spans epigenetics analysis, metagenomics, structural variation analysis, transcriptome sequencing, and whole genome sequencing, with transcriptome sequencing further differentiated into bulk and single-cell approaches and whole genome sequencing distinguished between human and non-human workflows. This diversity of applications drives distinct requirements for read length, base accuracy, and sample handling, which shapes provider specialization and informs decisions on platform deployment and analytical investments.

Based on technology, the landscape is effectively divided between Oxford Nanopore and Pacific Biosciences platforms, each offering discrete performance characteristics that influence suitability for particular applications. Nanopore systems are often favored for real-time sequencing and ultra-long reads, which support structural variant resolution and native modification detection, while the Pacific Biosciences approach emphasizes high consensus accuracy and robust circular consensus sequencing for complex genome assemblies and transcript isoform identification. Consequently, service providers craft differentiated packages that align platform strengths with client objectives.

Based on end user, demand is driven by biotechnology firms, diagnostic laboratories, pharmaceutical companies, and research institutes, each with unique procurement drivers and quality requirements. Biotech firms frequently prioritize rapid iteration and IP protection; diagnostic laboratories focus on clinical validation and regulatory compliance; pharmaceutical companies emphasize scalability for target validation and safety studies; and research institutes often value methodological flexibility and exploratory analyses. This segmentation informs how providers structure SLAs, documentation, and data deliverables.

Based on service provider type, offerings emerge from academic core facilities, contract research organizations, and hospital laboratories, with each segment exhibiting characteristic operational models. Academic cores emphasize methodological innovation and custom protocols, CROs provide regulated, end-to-end programs and project management capabilities, and hospital laboratories concentrate on clinical accreditation, sample traceability, and patient data governance. Understanding these intersecting segmentations is essential for both buyers seeking fit-for-purpose partners and providers positioning their services for sustainable differentiation.

A strategic regional perspective that contrasts adoption drivers, regulatory complexity, and capacity dynamics across the Americas, EMEA, and Asia-Pacific regions

Regional dynamics exert a powerful influence on service availability, partnership models, and regulatory expectations. The Americas have become a hub for translational research and clinical diagnostics, where dense networks of biotechnology firms, academic medical centers, and pharmaceutical headquarters drive demand for both high-throughput services and specialized assays. This concentration fosters rapid adoption of novel protocols and creates a competitive environment for service providers to demonstrate operational excellence and compliance with domestic regulatory frameworks.

Europe, the Middle East & Africa present a heterogenous landscape in which regulatory harmonization efforts coexist with diverse national policies and investment climates. In many European markets, public-private partnerships and collaborative research initiatives support access to advanced sequencing services, but variable reimbursement pathways and country-specific accreditation standards require providers to maintain flexible engagement strategies and robust documentation practices. In parts of the Middle East and Africa, capacity-building initiatives and targeted investments in laboratory infrastructure are creating new demand pockets, often focused on infectious disease genomics and population-scale studies.

Asia-Pacific has emerged as a region with accelerating adoption driven by significant biotechnology investments, expansive clinical trial activity, and an increasing base of high-throughput research centers. Several markets in the region have prioritized local manufacturing and distribution partnerships to reduce exposure to cross-border trade disruptions, and there is growing interest in integrating long-read capabilities into national genomics initiatives. Across all regions, localized regulatory expectations, talent availability, and infrastructure maturity are key determinants of how service offerings are configured and scaled.

A focused examination of competitive differentiation, partnership formations, and operational excellence that define company advantage in long-read sequencing services

Competitive dynamics among companies in the long-read sequencing services space center on technology alignment, service breadth, and the ability to deliver reproducible, regulatory-ready results. Technology providers that develop high-fidelity chemistries and scalable flow cells influence the service landscape by enabling providers to expand into higher-throughput or clinical-grade offerings. In parallel, service organizations differentiate through process standardization, bioinformatics expertise, and client-facing capabilities such as secure data pipelines and customizable reporting formats.

Partnerships and strategic alliances are increasingly important as vendors, service providers, and end users co-develop workflows that meet specific application needs. For example, collaborative programs that validate protocols for clinical use or that adapt platform chemistries for epigenetic detection strengthen credibility and reduce time-to-adoption. Intellectual property considerations and proprietary analysis tools also play a role in competitive positioning, as unique bioinformatics solutions can become a primary value driver for clients seeking actionable insight over raw data delivery.

Operational excellence, measured by turnaround consistency, documentation quality, and data traceability, remains a decisive differentiator for clients in regulated settings. Companies that can demonstrate rigorous quality management systems, validated analytical pipelines, and secure data governance protocols are more likely to secure long-term contracts with diagnostic laboratories and pharmaceutical partners. As a result, investments in quality certifications, clinical validation studies, and client education programs are common strategic priorities among leading organizations in the sector.

A pragmatic set of actionable recommendations that align platform selection, supply-chain resilience, and integrated service models to drive competitive leadership

Industry leaders should adopt a multi-pronged strategy that aligns technological capability with commercial agility and supply-chain resilience. First, prioritize platform-fit analyses that map application requirements-such as structural variation detection, native methylation calling, or single-cell transcriptomics-to the technical strengths and limitations of available platforms. This alignment ensures efficient allocation of capital and reduces rework associated with mismatch between assay design and platform performance.

Second, strengthen supply-chain robustness by diversifying suppliers, negotiating long-term agreements for critical consumables, and establishing regional inventory reserves where tariff exposure or logistical uncertainty is material. Complementary to procurement measures, invest in contractual flexibility that accommodates schedule variability without compromising client commitments. These steps will protect project continuity and preserve client trust during periods of external disruption.

Third, differentiate through integrated service models that marry sequencing execution with validated bioinformatics and clear regulatory documentation. Offering modular engagements-from raw data delivery to fully interpreted reports-allows providers to meet the needs of diverse end users while building pathways for deeper, recurring engagements. Finally, invest in client education and post-delivery support to translate complex genomic outputs into actionable insights, thereby increasing perceived value and reducing the barriers to adoption among diagnostic and pharmaceutical partners.

A transparent and replicable research methodology combining expert interviews, operational assessments, and secondary source synthesis to validate findings and implications

The research methodology underpinning this analysis combines qualitative expert inquiry, secondary literature synthesis, and structured operational assessment. Primary inputs were obtained through interviews with laboratory directors, service procurement leads, and platform engineers to capture frontline perspectives on technology performance, vendor relationships, and operational hurdles. These qualitative engagements were complemented by a systematic review of technical documentation, regulatory guidance, manufacturer specifications, and peer-reviewed literature to ensure accurate characterization of platform capabilities and application suitability.

Operational assessments focused on supply-chain mapping, turnaround-time benchmarking, and protocol reproducibility checks. Evidence was triangulated across multiple sources to validate claims about platform strengths and provider capabilities. Special attention was given to methodological transparency, with careful documentation of interview protocols, inclusion criteria for supplier evaluation, and the analytical frameworks used to compare technologies and service models.

Throughout the research process, ethical considerations and data governance principles were upheld. Confidential commercial information gleaned from interviews was anonymized where necessary, and claims were cross-verified to avoid overreliance on single sources. The methodology emphasizes replicability and clarity, enabling clients to trace findings back to source inputs and to adapt the approach for future, context-specific assessments.

A concise concluding synthesis that ties technology, commercial strategy, and operational resilience into a pragmatic outlook for long-read sequencing service stakeholders

In conclusion, long-read sequencing services are at an inflection point where technological maturity, evolving service models, and shifting macroeconomic conditions intersect to create both opportunity and complexity. Providers that align platform capabilities with clear application fit, invest in supply-chain resilience, and deliver integrated analytical packages will be best positioned to meet the diverse needs of biotechnology firms, diagnostic laboratories, pharmaceutical companies, and research institutes. Strategic differentiation will hinge less on instrument ownership alone and more on the ability to provide reproducible, regulatory-aware, and insight-driven services.

Practically speaking, stakeholders should prioritize investments that reduce friction across the project lifecycle-improving sample handling, validating analytical pipelines, and enhancing client communication. Simultaneously, attention to regional regulatory requirements and the implications of trade policy will be essential to maintaining continuity and trust. By focusing on these priorities, organizations can transform advances in long-read sequencing into durable competitive advantage and measurable research impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long-Read Sequencing Services Market, by Technology

  • 8.1. Oxford Nanopore
  • 8.2. Pacific Biosciences

9. Long-Read Sequencing Services Market, by Service Provider

  • 9.1. Academic Core Facility
  • 9.2. Contract Research Organization
  • 9.3. Hospital Laboratory

10. Long-Read Sequencing Services Market, by Application

  • 10.1. Epigenetics Analysis
  • 10.2. Metagenomics
  • 10.3. Structural Variation Analysis
  • 10.4. Transcriptome Sequencing
    • 10.4.1. Bulk
    • 10.4.2. Single Cell
  • 10.5. Whole Genome Sequencing
    • 10.5.1. Human
    • 10.5.2. Non-Human

11. Long-Read Sequencing Services Market, by End User

  • 11.1. Biotechnology Firms
  • 11.2. Diagnostic Laboratories
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Long-Read Sequencing Services Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long-Read Sequencing Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long-Read Sequencing Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Long-Read Sequencing Services Market

16. China Long-Read Sequencing Services Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arima Genomics, Inc.
  • 17.6. Azenta, Inc.
  • 17.7. Bionano Genomics, Inc.
  • 17.8. Circulomics, Inc.
  • 17.9. DNAnexus, Inc.
  • 17.10. Eurofins Genomics LLC
  • 17.11. Fulgent Genetics, Inc.
  • 17.12. Genewiz, Inc.
  • 17.13. LGC Genomics Ltd.
  • 17.14. MicrobesNG Ltd.
  • 17.15. Nucleics Pty Ltd
  • 17.16. Oxford Nanopore Technologies plc
  • 17.17. Pacific Biosciences of California, Inc.
  • 17.18. Plenty Labs Inc.
  • 17.19. Primordium Labs LLC
  • 17.20. Psomagen, Inc.
  • 17.21. Ramaciotti Centre for Genomics
  • 17.22. SeqCenter LLC
  • 17.23. Sequencing.com, Inc.
  • 17.24. The Genome Analysis Centre Ltd.
  • 17.25. Veritas Genetics, Inc.
  • 17.26. Whole Genome Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LONG-READ SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PACIFIC BIOSCIENCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PACIFIC BIOSCIENCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PACIFIC BIOSCIENCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC CORE FACILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC CORE FACILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC CORE FACILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HOSPITAL LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HOSPITAL LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY EPIGENETICS ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY EPIGENETICS ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY EPIGENETICS ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY STRUCTURAL VARIATION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY STRUCTURAL VARIATION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY STRUCTURAL VARIATION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BULK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BULK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BULK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SINGLE CELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SINGLE CELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SINGLE CELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HUMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HUMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY NON-HUMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY NON-HUMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY NON-HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 132. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 133. GCC LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 153. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 154. G7 LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 160. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 161. NATO LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL LONG-READ SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA LONG-READ SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)